Soft Tissue Sarcomas Clinical Trials

24 clinical trials for Soft Tissue Sarcomas across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas — RECRUITING · PHASE1
• A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions — RECRUITING · PHASE1
• IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) — RECRUITING · PHASE2
• CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. — RECRUITING · NA
• Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas — RECRUITING · PHASE2
• Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas — WITHDRAWN · NA
• Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas — ACTIVE_NOT_RECRUITING · NA
• Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide — COMPLETED · PHASE1
• Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE — COMPLETED
• The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities — OTHER · PHASE2
• Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas — COMPLETED · PHASE2
• A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors — TERMINATED · PHASE1
• Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS — OTHER
• Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule — COMPLETED · PHASE4
• Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma — OTHER · PHASE2
• Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients — TERMINATED · PHASE2
• Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas — WITHDRAWN · PHASE2
• Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas — WITHDRAWN · PHASE2
• RAD001 in Advanced Sarcoma — COMPLETED · PHASE2
• The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). — COMPLETED · PHASE2
• Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) — COMPLETED · PHASE1
• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. — COMPLETED · PHASE1
• 11C-Acetate PET/CT Non-FDG-Avid Tumors — OTHER

Refine this search